511MO A phase I study of SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-β, in patients with advanced non-small cell lung cancer (NSCLC)
Authors:
- J. FengJFJ. Feng
- M. ShiMSM. Shi
- J. ChenJCJ. Chen
- K. LiKLK. Li
- X. LiXLX. Li
- M. SunMSM. Sun
- B. LiBLB. Li
- G. WenGWG. Wen
- Y. FangYFY. Fang
- X. MinXMX. Min
- L. LinLLL. Lin
- Y. LiuYLY. Liu
- 2 December 2023
- journal article
- abstracts
- Published by Elsevier in Annals of Oncology
- Vol. 34, S1667